SCHEMBL5315433

SCHEMBL5315433

CCOCc1c(C(=O)NOC(C)=O)ncc2cc(Oc3ccccc3)ccc12

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 13/20 0.50
EGLN2 Q96KS0 17/20 0.48
THRA P10827 2/20 0.42
THRB P10828 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5315695 0.91 EGLN1 (0.49) EGLN1EGLN2
SCHEMBL6060364 0.86 EGLN1 (0.52) EGLN1EGLN2THRATHRB
SCHEMBL3914540 0.85 EGLN1 (0.70) EGLN1EGLN2THRATHRB
SCHEMBL6060946 0.83 EGLN1 (0.49) EGLN1EGLN2
SCHEMBL28911350 0.83 EGLN1 (0.68) EGLN1EGLN2
SCHEMBL6059995 0.81 EGLN1 (0.56) EGLN1EGLN2THRATHRB
SCHEMBL20774561 0.78 EGLN1 (0.50) EGLN1EGLN2
SCHEMBL4111418 0.77 EGLN1 (0.71) EGLN1EGLN2THRATHRB
SCHEMBL3924768 0.76 EGLN2 (0.51) EGLN1EGLN2
SCHEMBL3917940 0.76 EGLN2 (0.51) EGLN1EGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007047194-A2 METHODS FOR TREATING MITF-RELATED DISORDERS DANA-FARBER CANCER INSTITUTE, INC. (US) 2007-04-26 WO disclosed